Liver Cirrhosis-Common Clinical Problem

Ruchi Singh; Dr. Afroze Alam; Vinod Kumar; B.D. Tripathi; Amrendra Yadav

Authors

Ruchi Singh
Dr. Afroze Alam
Vinod Kumar
B.D. Tripathi
Amrendra Yadav

Keywords:

cirrhosis, splenomegaly, autoimmune hepatitis

Abstract

The liver is the multi-functional and vital organ of the body. It is found in the upper abdomen region of the vertebrates. Due to long-term damage, liver stops functioning properly which may lead to cirrhosis. This long-term damage occurred when scar tissue replaces the normal tissue of the liver. This disease develops slowly and has no early symptoms, but when it develops and become worse, then it leads to tiredness, itchiness, weakness, yellow skin, swelling in the lower legs, spider-like blood vessels and an easy bruise on the skin with fluid in the abdomen. The severe complications like bleeding dilated veins in esophagus or stomach, hepatic encephalopathy leading to confusion and unconsciousness and liver cancer may occur in the body. This review article is focusing on the effect of liver damage in the human body.

Downloads

How to Cite

Liver Cirrhosis-Common Clinical Problem. (2019). Global Journal of Medical Research, 18(B5), 23-25. https://medicalresearchjournal.org/index.php/GJMR/article/view/1674

Download Citation

References

P Marcellin, M Buti, E Gane (2011) Five years of treatment with tenofovir DF (TDF) for chronic hepatitis B (CHB) infection is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis. 54.

J Bircher, J Benhamou, N Mcintyre, M Rizzetto, J Rodes (1999) Oxford Textbook of Clinical Hepatology.

Fenton Schaffner, Hans Popper (1963) Capillarization of Hepatic Sinusoids in Man. 44(3), 239-242.

S Sherlock, J Dooley (2002) Diseases of the Liver and Biliary System.

Schiff E R, M F Sorrell, E Maddrey (2003) Schiff's Diseases of the Liver.

(1994) Digestive diseases in the United States: Epidemiology and Impact.

H Conn, C Atterbury (1993) Cirrhosis. 875-934.

S Erlinger, J Benhamou (1991) Cirrhosis: Clinical aspects. 380.

D Pratt, M Kaplan (1999) Evaluation of the Liver A: Laboratory Tests. 205.

René Adam, Vincent Karam, Valérie Delvart, John O'grady, Darius Mirza, Jurgen Klempnauer, Denis Castaing, Peter Neuhaus, Neville Jamieson, Mauro Salizzoni, Stephen Pollard, Jan Lerut, Andreas Paul, Juan Garcia-Valdecasas, Fernando Rodríguez, Andrew Burroughs (2012) Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). 57(3), 675-688.

A Singal (2010) A sustained viral response is associated with reduced liverrelated morbidity and mortality in patients with hepatitis C virus. 8(3), 280-288.

T Frieden (1999) Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis. 29(3), 883-888.

Juan García-Pagán, Karel Caca, Christophe Bureau, Wim Laleman, Beate Appenrodt, Angelo Luca, Juan Abraldes, Frederik Nevens, Jean Vinel, Joachim Mössner, Jaime Bosch (2010) Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding. 362(25), 2370-2379.

G Kalambokis, A Mouzaki, M Rodi (2012) Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. 10, 815-818.

Michael Charlton, Paul Pockros, Stephen Harrison (2006) Impact of obesity on treatment of chronic hepatitis C†. 43(6), 1177-1186.

Study, Liver (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. 57, 167-185.

Ian Wanless, Florence Wong, Lawrence Blendis, Paul Greig, Jenny Heathcote, Gary Levy (1995) Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension. 21(5), 1238-1247.

(1995) Propanolol does not decrease the development of large esophageal varices in patients with cirrhosis. A controlled study Groupe Fran�ais de la Pr�vention Pr�-Primaire*. 22(4), A155.

S Abid, K Mumtaz, Z Abbas, S Hamid, N Jafri, S Ali (2005) 215 Efficacy of infusion of L-ornithine L-aspartate in cirrhotic patients with portosystemic encephalopathy: A placebo controlled study. 42(2), 84.

D Adebayo, C Bureau, D Valla, M Peck-Radosavljevic, A Mccune, V Vargas (2015) Alfapump system versus large volume paracentesis in the treatment of refractory ascites. A multicenter randomised controlled study. 62(2), 849-S850.

C Ahmed, S Chaudhary, I Khan (2014) Comparison of intravenous ciprofloxacin and ceftriaxone in the management of spontaneous bacterial peritonitis in cirrhosis of liver at Mayo Hospital, Lahore. 8(1), 82-84.

Richard Allan, Kerry Thoirs (2014) A comparison of liver surface and hepatic vein wall ultrasound as markers for fibrosis or cirrhosis of the liver. 20(1), 8-14.